Thyroid: confirm diagnosis of papillary thyroid carcinoma in cytology or equivocal cases (Arch Pathol Lab Med 2003;127:579, Mod Pathol 2006;19:1631); help distinguish follicular variant of …

CK19 immunohistochemistry has been used successfully in thyroid tumors to recognize papillary carcinomas for some time. However, its use in the pancreas, liver, and gastrointestinal tract …

2021年9月1日 · Data suggested a specific diagnostic role of CK19 immunohistochemistry (IHC) in several applications, for example, for the diagnosis of dysplasia in nonkeratinizing squamous …

CK： 细胞角蛋白 （cytokeratin)家族有CK7，CK8，CK9，CK19，CK20等多个成员。 一般认为，CK7、Ck19是胆管上皮的标志物，是胆管上皮癌和肝细胞癌鉴别诊断的标志物。

Cytokeratin 19 (CK19) is well acknowledged as a biliary/progenitor cell marker and a marker of tumor stem cell. CK19-positive HCCs demonstrate aggressive behaviors and poor outcomes …

为了评估正常和癌组织中细胞角蛋白 19 (CK19) 的表达，通过免疫组织化学 (IHC) 分析了来自 122 种肿瘤类型的 15,977 个样本和 76 个正常组织类型的 608 个样本。

In contrast, follicular variant of papillary thyroid carcinoma (FV-PTC) shows mostly 3+ staining intensity for ck19 in IHC staining (the lower diagram). The y axis shows the number of lesions …

在肝细胞、胆管及肝细胞肝癌（HCC）、肝内胆管癌（ICC）和转移性癌中几乎 100% 表达。 CK19/CK7. 常被称为 胆管型细胞角蛋白，表达于 ICC，而在 HCC 中不表达，可用于 HCC 和 …

Among the various markers used in IHC, CK19 is a particularly sensitive marker that plays a crucial role in aiding cancer diagnosis. Its use represents a promising avenue for reducing the …

Cytokeratin 19 is recommended for the detection of specific antigens of interest in normal and neoplastic tissues, as an adjunct to conventional histopathology using non-immunologic …